Zephyr AI
Healthcare Software · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 Tysons Blvd Ste 901, Mc Lean, Virgi...Phone Number
(202) 539-7022Website
zephyrai.bioRevenue
$7.9 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
2
3
2
2
About Zephyr AI
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. Through partnerships and proprietary data, Zephyr AI is curating the worlds most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support patients and providers and fuel ongoing research. At Zephyr AI, their mission-focused team of world-class software engineers and biologists leverage big data and next-generation technology to derive transformational insights and build enduring partnerships that will revolutionize the treatment of cancer and cardiometabolic disease.Explore more
Zephyr AI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zephyr AI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Zephyr AI, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Zephyr AI has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Zephyr AI has new funding data
Check out if Zephyr AI is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zephyr AI
Earning: See what the market has to say on Zephyr AI recently announced quarterly report
Product Launch: Get notified when Zephyr AI launches new products
Click to see if Zephyr AI had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Zephyr AI
Compare insights from companies similar to Zephyr AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zephyr AI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Zephyr AI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Zephyr AI.
Zephyr AI financials insights
Gather financial insights about Zephyr AI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Angel/Seed
$18.5M
2024
Series A
$111M
Private Equity
$60M
Zephyr AI Tech Stack
A closer look at the technologies used by Zephyr AI
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Zephyr AI News & Media
Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer Patients
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision medicine in cancer drug development, presented a poster today at the Annual Meeting for the American Society of Clinical Oncology (ASCO). Entitled “Evaluation of a novel signature for PARP inhibitor sensitivity prediction using real-world data,” the presentation demonstrates the game-changing patient insights that AI canZephyr AI Announces the Appointment of John Applegate as its CFO
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, Inc., a high-growth healthcare technology company committed to developing artificial intelligence (AI) solutions to democratize precision medicine, has announced that veteran biotechnology executive John Applegate has joined the company as Chief Financial Officer. “With John’s appointment, Zephyr continues to demonstrate its ability to attract some of the best and brightest talent,” said Zephyr’s Co-Founder, Interim CEO, and Chief Technology Officer JeffZephyr AI Raises $111 Million in Series A Financing | Healthcare IT Today
Latest Investment Will Support the Democratization of Precision Medicine Through the Advancement of Novel Explainable AI Algorithms Zephyr AI, Inc. (Zephyr AI), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, today announced it has successfully closed a $111 million Series A funding round with participationRachael Brake, PhD, Joins Zephyr AI as Chief Scientific Officer
MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (“Zephyr AI”), a healthcare technology company committed to developing fast and explainable artificial intelligence (AI) solutions to democratize precision medicine, today announced the appointment of Rachael Brake, PhD, as its new Chief Scientific Officer. “Having spent decades working in big pharma and biotech spanning roles in research, development and commercial, Rachael comes to Zephyr with a unique breadth of experience,” said Jeff Sherman, Ze
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zephyr AI
Sign Up For FreeTo access detailed company insights
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. Through partnerships and proprietary data, Zephyr AI is curating the worlds most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel... Read More
